Bicycle Therapeutics

BCYCNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$254.074 M

$3.63 -0.55%

Close of 21 Sept 2026

Revenue

$72.6M

#2609 by revenue

Earnings

-$219.0M

Loss-making

Shares outstanding

69,814,145

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#250Akebia TherapeuticsAKBA$260.1M
#251Entrada TherapeuticsTRDA$258.5M
#252Bicycle TherapeuticsBCYC$254.1M
#253Foghorn TherapeuticsFHTX$246.4M
#254Cartesian TherapeuticsRNAC$240.2M

What if Bicycle Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$432,530.54

Per share 119,154× higher

Bitcoin $1.72T

$24,571.13

Per share 6,769× higher

Nvidia $5.48T

$78,291.66

Per share 21,568× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Bicycle Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.